Document Detail

Chylomicron metabolism by the isolated perfused mouse heart.
MedLine Citation:
PMID:  11440913     Owner:  NLM     Status:  MEDLINE    
The catabolism of rat chylomicrons, labeled in their triacylglycerol (TG) component, was investigated using perfused working mouse hearts. Perfusion of mouse hearts with heparin increased lipoprotein lipase (LPL) activity in the perfusate. This heparin-releasable LPL pool remained constant over a variety of experimental conditions, including workload and fatty acid concentrations, making the mouse heart a suitable model to study chylomicron catabolism. Endothelium-bound LPL hydrolyzed radiolabeled (3)H-labeled chylomicrons (0.4 mM TG); the fate of LPL-derived (3)H-labeled fatty acids was split evenly between oxidation (production of (3)H(2)O) and esterification (incorporation into tissue lipids, mainly TG). In comparison, the oxidation of 0.4 mM [(3)H]palmitate complexed to albumin was fourfold greater than esterification into tissue lipids. Surprisingly, the addition of unlabeled palmitate (0.4 or 1.2 mM) to perfusions with (3)H-chylomicrons did not affect the fate (either oxidation or esterification) of LPL-derived (3)H-fatty acids. These results suggest that fatty acids produced from lipoprotein hydrolysis by the action of LPL and fatty acids from a fatty acid-albumin complex do not enter a common metabolic pool in the heart.
K Mardy; D D Belke; D L Severson
Related Documents :
8446653 - Effect of pravastatin on fatty acid profile of low density lipoprotein in patients with...
14988233 - Systemic and forearm triglyceride metabolism: fate of lipoprotein lipase-generated glyc...
16391083 - Aerobic biodegradation of 2,2'-dithiodibenzoic acid produced from dibenzothiophene meta...
Publication Detail:
Type:  In Vitro; Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  American journal of physiology. Endocrinology and metabolism     Volume:  281     ISSN:  0193-1849     ISO Abbreviation:  Am. J. Physiol. Endocrinol. Metab.     Publication Date:  2001 Aug 
Date Detail:
Created Date:  2001-07-06     Completed Date:  2001-08-09     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  100901226     Medline TA:  Am J Physiol Endocrinol Metab     Country:  United States    
Other Details:
Languages:  eng     Pagination:  E357-64     Citation Subset:  IM    
Department of Pharmacology and Therapeutics, Faculty of Medicine, University of Calgary, Calgary, Alberta, Canada T2N 4N1.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Chylomicrons / metabolism*,  pharmacology
Dose-Response Relationship, Drug
Endothelium, Vascular / metabolism
Enzyme Activation / drug effects
Esterification / drug effects
Heart / drug effects
Heparin / pharmacology
Lipoprotein Lipase / metabolism
Macromolecular Substances
Models, Cardiovascular
Myocardial Contraction / physiology
Myocardium / metabolism*
Oxidation-Reduction / drug effects
Palmitic Acid / metabolism,  pharmacology
Serum Albumin / metabolism
Reg. No./Substance:
0/Chylomicrons; 0/Macromolecular Substances; 0/Serum Albumin; 10028-17-8/Tritium; 57-10-3/Palmitic Acid; 9005-49-6/Heparin; EC Lipase

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Effect of protein restriction on (15)N transfer from dietary [(15)N]alanine and [(15)N]Spirulina pla...
Next Document:  BCAA intake affects protein metabolism in muscle after but not during exercise in humans.